Timothy Voorhees

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook et al. · Blood · 2021 · 91 citations · Full text

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown et al. · Blood Advances · 2020 · 82 citations · Full text

Cell Therapy, Na Exposure, Chronic Lymphocytic Leukemia +18

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

Timothy Voorhees, Beibo Zhao, Jorge D. Oldan et al. · Blood Advances · 2021 · 45 citations · Full text

Lymphoid Neoplasia, Radiation Oncology, Hodgkin Lymphoma +15

Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study

Steven W. Cotten, Zahra Shajani-Yi, Mark A Cervinski et al. · Clinical Biochemistry · 2018 · 40 citations

Reference Intervals, Biomarker (Medicine), Disease Progression +10

<scp>Real‐world</scp> evidence of the safety and survival with <scp>CD19 CAR‐T</scp> cell therapy for relapsed/refractory solid organ <scp>transplant‐related PTLD</scp>

Marshall McKenna, Narendranath Epperla, Armin Ghobadi et al. · British Journal of Haematology · 2023 · 33 citations · Full text

Cell Therapy, Immunology, Transplantation Medicine +18